U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT06832878) titled 'Postoperative Oral Tranexamic Acid in Patients Undergoing Primary Total Joint Arthroplasty' on Feb. 13.
Brief Summary: The purpose of this study is to evaluate the impact of an extended oral Tranexamic Acid regimen on patient reported outcome scores, time to independent ambulation, postoperative range of motion, swelling, change in hemoglobin levels, 90-day complications, readmission and reoperation.
Study Start Date: March 01
Study Type: INTERVENTIONAL
Condition:
Arthroplasty
Intervention:
DRUG: Oral Tranexamic Acid
Subjects will receive a 1.95 g dose of oral TXA at the following timepoints: (1) following ambulation, (2) pos...